From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
about
Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cellsDrug utilization pattern in patients with different types of dementia in Western India.Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.Effect of Caffeine Chronically Consumed During Pregnancy on Adenosine A1 and A2A Receptors Signaling in Both Maternal and Fetal Heart from Wistar RatsLifestyle Factors and Dementia in the Oldest-old: The 90+ Study.Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration.Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study.A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation.Design, synthesis and evaluation of 2-aryl benzoxazoles as promising hit for the A2A receptor.Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors.Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity.The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's DiseaseBeneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease
P2860
Q28385402-E6DA2061-B5C6-42EC-847C-BE5EEAE5AD7AQ34176659-C8D113C1-F754-46AE-9A0C-7B469EFDF6F2Q34540333-152F483E-213D-471C-9A31-CAD452507170Q34709509-61ADE734-976C-4D4A-99B9-7708FCC2C975Q36031659-0CAC3418-4DE1-4493-8AE1-9E1F633B76F5Q38691042-7737430E-72D4-4304-895A-111467CFFD46Q40563346-445C2CAA-EAB8-4F03-A2CA-6C0210893390Q41755392-1B288D0E-8DF7-43BF-9704-FBC9E5DC9683Q42269908-F7BECABA-4BDD-47F5-9EAB-090F913841CFQ50917169-39DBF112-D705-44F4-9919-003487BB3F78Q55003224-F7A43180-6D91-4C91-B390-0B63C8AC1AA2Q55547635-9219BB09-2A08-477E-A649-CF623EA2C424Q57896320-E47691C0-9AE6-490E-9CD3-8C3E71EE1B9EQ57896338-9A419ED0-6B5A-4904-8646-B857F1EFB940
P2860
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
@ast
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
@en
type
label
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
@ast
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
@en
prefLabel
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
@ast
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
@en
P2093
P2860
P50
P356
P1476
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?
@en
P2093
Cyril Laurent
Sandrine Humez
Sylvie Burnouf
Ursula Sandau
Vanessa Flaten
P2860
P304
P356
10.1042/BST20130229
P577
2014-04-01T00:00:00Z